eutralizing antibodies and clinical isolates of human immunodeficiency viruses (HIV).
Not Applicable
Recruiting
- Conditions
- HIV infection
- Registration Number
- JPRN-UMIN000004720
- Lead Sponsor
- Matsushita project, Center for AIDS Research, Kumamoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who have difficulty to donate additional blood because of some complications such as severe anemia 2.Patients under treatment of immune suppressive agents or anti-cancer agents. 3.Patients under treatment with interferon. 4.Patients who are determined not appropriate for the study by attending doctors.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Establishment of neutralizing monoclonal antibodies against HIV. Isolation of HIV from patients with recent infection.
- Secondary Outcome Measures
Name Time Method